Citadel Advisors’s Skylight Health Group Inc Common Shares SLHG Stock Holding History

Citadel Advisors’s Portfolio SLHG Stock Details SLHG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-70,431	Closed	-$34K	–	14212
2022 Q2	$34K	Buy	+70,431	New	+$55K	﹤0.01%	12163
2022 Q1	–	Sell	-49,262	Closed	-$64K	–	15135
2021 Q4	$64K	Buy	+49,262	New	+$104K	﹤0.01%	13105
2021 Q3	–	Sell	-17,354	Closed	-$71K	–	15124
2021 Q2	$71K	Buy	+17,354	New	+$78.1K	﹤0.01%	13160

Citadel Advisors's SLHG Position: Q3 2022 in Review

Citadel Advisors sold out of Skylight Health Group Inc Common Shares (SLHG) in Q3 2022, closing a stake of 70,431 shares — an estimated $34K sold.

Citadel Advisors first reported a position in SLHG in Q2 2021 and held it in 3 quarters. The position peaked at $71K in Q2 2021. 0 funds tracked by Wall St. Rank hold SLHG as of Q3 2022.

Citadel Advisors reported no remaining Skylight Health Group Inc Common Shares position as of Q3 2022 after selling out during the quarter.
Citadel Advisors sold 70,431 Skylight Health Group Inc Common Shares shares in Q3 2022, an estimated $34K.
Citadel Advisors first reported a position in Skylight Health Group Inc Common Shares in Q2 2021 and held it in 3 quarters.
Citadel Advisors's Skylight Health Group Inc Common Shares position peaked at $71K in Q2 2021.
0 funds tracked by Wall St. Rank held Skylight Health Group Inc Common Shares as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.